BDP Bio
- Biotech or pharma, therapeutic R&D
BDP Bio is partnering with a stealth biotech to start a promising Phase III study for a Dendritic Cell therapy in women with acute platinum-sensitive ovarian cancer to be used in combination with Standard of Care. Phase 1/2 studies have demonstrated significantly promising efficacy in Overall and Progression-Free Survival in Ovarian tumor combination therapy compared to SOC alone.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}